Remove Bacteria Remove Genome Remove Reagent
article thumbnail

BioSpace Global Roundup: Ipsen Wins Fast Track Designation for Cancer Drug and More

The Pharma Data

aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. Financial details of the agreement were not disclosed.

Drugs 52
article thumbnail

BioSpace Global Roundup, Oct. 15

The Pharma Data

ERS Genomics – Ireland’s ERS Genomics signed an agreement with FASMAC Co., Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. The patent is valid through 2038. Ltd of Japan.

article thumbnail

Emerging Trends in Protein Expression Systems: Growth Opportunities And Future Outlook

Roots Analysis

Transformation / Transfection: The expression vector is introduced into the host organism (bacterial, yeast, insect, algal, cell-free or mammalian cells) through transformation (for bacteria and yeast) or transfection (for mammalian cells).

Protein 40